Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Apr 25;27(6):441–446. doi: 10.1093/oncolo/oyac075

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2022. Published by Oxford University Press.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Figure 2. — Overall survival. CDK, cyclin-dependent kinases 4/6 inhibitors; Chemo, cytotoxic chemotherapy; F, fulvestrant; mTOR, mammalian target of rapamycin inhibitor (everolimus). “Other” includes endocrine therapies, various targeted therapies, trial drugs, etc. that do not fit into any of the other 4 categories.